Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance

MLA

Kiyoshi Takatsu, et al. “Eplerenone Prevented Obesity-Induced Inflammasome Activation and Glucose Intolerance.” Journal of Endocrinology, vol. 235, Dec. 2017, pp. 179–91. EBSCOhost, https://doi.org/10.1530/joe-17-0351.

APA

Kiyoshi Takatsu, Yuto Nakamura, Tsutomu Wada, Yasuhiro Onogi, Yoshinori Nagai, Yoko Ishii, Yusuke Aruga, Masakiyo Sasahara, Hiroshi Tsuneki, Hiroe Honda, Eri Watanabe, Akari Ishikawa, Daisuke Koya, Hayate Hasegawa, & Toshiyasu Sasaoka. (2017). Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance. Journal of Endocrinology, 235, 179–191. https://doi.org/10.1530/joe-17-0351

Chicago

Kiyoshi Takatsu, Yuto Nakamura, Tsutomu Wada, Yasuhiro Onogi, Yoshinori Nagai, Yoko Ishii, Yusuke Aruga, et al. 2017. “Eplerenone Prevented Obesity-Induced Inflammasome Activation and Glucose Intolerance.” Journal of Endocrinology 235 (December): 179–91. doi:10.1530/joe-17-0351.